| Key Financial Ratios of Sun Pharmaceutical Industries (in Rs. Cr.) |
Mar 20 |
Mar 19 |
Mar 18 |
Mar 17 |
Mar 16 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
13.40 |
3.40 |
1.30 |
-0.10 |
-4.50 |
|
| Diluted EPS (Rs.) |
13.40 |
3.40 |
1.30 |
-0.10 |
-4.50 |
|
| Cash EPS (Rs.) |
15.72 |
5.71 |
3.30 |
1.66 |
-2.53 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
101.68 |
95.21 |
93.04 |
87.58 |
89.27 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
101.68 |
95.21 |
93.04 |
87.58 |
89.27 |
|
| Dividend / Share(Rs.) |
4.00 |
2.75 |
2.00 |
3.50 |
1.00 |
|
| Revenue from Operations/Share (Rs.) |
52.23 |
42.94 |
37.54 |
32.03 |
31.64 |
|
| PBDIT/Share (Rs.) |
17.60 |
12.62 |
8.78 |
2.62 |
-0.01 |
|
| PBIT/Share (Rs.) |
15.26 |
10.31 |
6.75 |
0.86 |
-1.94 |
|
| PBT/Share (Rs.) |
13.56 |
3.00 |
1.17 |
-0.07 |
-4.44 |
|
| Net Profit/Share (Rs.) |
13.38 |
3.40 |
1.27 |
-0.10 |
-4.46 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
33.69 |
29.38 |
23.38 |
8.18 |
-0.04 |
|
| PBIT Margin (%) |
29.21 |
24.01 |
17.97 |
2.69 |
-6.13 |
|
| PBT Margin (%) |
25.95 |
6.98 |
3.11 |
-0.21 |
-14.02 |
|
| Net Profit Margin (%) |
25.62 |
7.92 |
3.39 |
-0.29 |
-14.09 |
|
| Return on Networth / Equity (%) |
13.16 |
3.57 |
1.36 |
-0.10 |
-4.99 |
|
| Return on Capital Employed (%) |
13.45 |
10.12 |
6.68 |
0.90 |
-1.84 |
|
| Return on Assets (%) |
8.36 |
2.16 |
0.83 |
-0.06 |
-3.13 |
|
| Total Debt/Equity (X) |
0.24 |
0.26 |
0.30 |
0.23 |
0.26 |
|
| Asset Turnover Ratio (%) |
0.33 |
0.28 |
0.25 |
0.23 |
0.21 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.07 |
0.84 |
0.76 |
0.58 |
0.60 |
|
| Quick Ratio (X) |
0.83 |
0.63 |
0.59 |
0.37 |
0.36 |
|
| Inventory Turnover Ratio (X) |
1.18 |
1.11 |
0.99 |
1.00 |
0.93 |
|
| Dividend Payout Ratio (NP) (%) |
42.94 |
58.67 |
261.00 |
-1,053.76 |
-22.42 |
|
| Dividend Payout Ratio (CP) (%) |
36.55 |
34.98 |
100.61 |
60.25 |
-39.49 |
|
| Earnings Retention Ratio (%) |
57.06 |
41.33 |
-161.00 |
1,153.76 |
122.42 |
|
| Cash Earnings Retention Ratio (%) |
63.45 |
65.02 |
-0.61 |
39.75 |
139.49 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
89,593.53 |
120,496.23 |
125,484.55 |
169,644.26 |
202,702.44 |
|
| EV/Net Operating Revenue (X) |
7.15 |
11.70 |
13.93 |
22.08 |
26.62 |
|
| EV/EBITDA (X) |
21.22 |
39.80 |
59.58 |
269.68 |
-64,146.34 |
|
| MarketCap/Net Operating Revenue (X) |
6.74 |
11.16 |
13.20 |
21.47 |
25.90 |
|
| Retention Ratios (%) |
57.05 |
41.32 |
-161.00 |
1,153.76 |
122.42 |
|
| Price/BV (X) |
3.46 |
5.03 |
5.32 |
7.85 |
9.18 |
|
| Price/Net Operating Revenue |
6.74 |
11.16 |
13.20 |
21.47 |
25.90 |
|
| Earnings Yield |
0.04 |
0.01 |
0.00 |
0.00 |
-0.01 |
|
Source : Dion Global Solutions Limited
